Given the critical role of IL-6 in regulating the balance between the Treg and the Th17 cells, controlling IL-6 activities by MMP-3 is a potentially effective approach to treat not only mild irreversible pulpitis but also various chronic inflammatory diseases. The gene discussed is IL6; the disease is pulpitis.